Lipocine News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.05.18	Lipocine Announces Financial and Operational Results for the First Quarter Ended March 31, 2018 (PR Newswire)
28.04.18	Biotech Stocks Facing FDA Decision In May (RTTNews)
21.03.18	Lipocine to Present at the 17th Annual Needham Healthcare Conference (PR Newswire)
14.03.18	Lipocine to Present at the Oppenheimer 28th Annual Healthcare Conference (PR Newswire)
12.03.18	Lipocine Announces Financial and Operational Results for the Fiscal Year Ended December 31, 2017 (PR Newswire)
05.03.18	Lipocine to Present at the 30th Annual ROTH Conference (PR Newswire)
01.03.18	ECYT Has VISION, LPCN Up 50% In 5 Days, MYO On Watch, FDA Nod Boosts SRNE (RTTNews)
28.02.18	TTOO Gains Steam, LPCN Up On Upgrade, ALDX Abuzz (RTTNews)
17.02.18	LIPOCINE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lipocine Inc. - LPCN (PR Newswire)
08.02.18	Lipocine Announces $10 Million Loan and Security Agreement with Silicon Valley Bank (PR Newswire)
07.02.18	Lipocine to Present at the LEERINK Partners 7th Annual Global Healthcare Conference (PR Newswire)
11.01.18	Lipocine's Oral Testosterone Drug Fails To Win FDA Panel Backing (RTTNews)
10.01.18	Lipocine Announces Outcome of FDA Advisory Committee Meeting for TLANDO™, Testosterone Replacement Therapy in Adult Males with Hypogonadism (PR Newswire)
10.01.18	LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again (RTTNews)
27.12.17	Biotech Stocks Facing FDA Decision In January 2018 (RTTNews)
19.10.17	FDA Blesses 2nd CAR-T Cell Therapy, NVO One Step Away From Approval, AKTX Slumps (RTTNews)
21.09.17	FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ (RTTNews)
23.08.17	Daily Technical Summary Reports on Generic Drugs Stocks -- Collegium Pharma, Momenta Pharma, Lipocine, and Diplomat Pharma (PR Newswire)
15.08.17	FDA Lifts Hold On CVM's Study, FATE On Track, REGN, OPHT, ZYNE All Flunk Trials (RTTNews)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
20.06.17	AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade (RTTNews)
12.01.17	Research Reports Coverage on Healthcare Stocks -- Pacira Pharma, Supernus Pharma, Lipocine, and IntelliPharmaCeutics (PR Newswire)
06.01.17	OTIC Hits Right Notes, GEMP To Report Data This Month, Busy Year Ahead For RVNC (RTTNews)
06.12.16	CERC's Woes Continue, TXMD Replenished By Trial Data, NDRM Abuzz, SRNE On Watch (RTTNews)
14.10.16	Watch Out For CTRV, FDA Delays Decision On EGLT, OGXI In Low Spirits (RTTNews)
10.10.16	FDA Says No To Nicox, Lundbeck's Persistence Pays Off, It's A Win For LPCN (RTTNews)
27.09.16	ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial (RTTNews)
29.06.16	Lipocine Gets CRL From FDA For LPCN 1021 - Quick Facts (RTTNews)
29.05.16	Biotech Stocks Facing FDA Decision In June (RTTNews)
17.02.16	FLXN Flexes Muscles, FDA Approves Broader Use Of Harvoni, Headache For TNXP (RTTNews)
01.09.15	AIMT Is Nothing To Sneeze At, AGRX Secured, TiGenix Admired, ICPT Gets FDA Date (RTTNews)
16.06.15	AERI Rockets On FDA Feedback, ADXS On The Job, ITCI To Report Trial Data In Q3 (RTTNews)
09.06.15	OCLS Gets A Facelift, NBIX Halts Trials, CBYL For The Long Haul, CMRX On Track (RTTNews)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
27.04.15	LPCN Prices Offering At $6.50/Share (RTTNews)
25.03.15	CLRB Sets Agenda, FDA Authorizes Xpert Ebola, Lpath Loses Track, OCAT Eyes PSCs (RTTNews)
13.10.14	Lipocine Announces Positive Top-line Results From Phase 2a Study Of LPCN 1111 (RTTNews)
25.09.14	ACOR Opens Wallet, CYNO Gets FDA Nod, INO To Advance Ebola Vaccine Study (RTTNews)
24.09.14	Lipocine: LPCN 1021 Meets FDA Primary Efficacy Guideline - Quick Facts (RTTNews)
19.09.14	It's Time To Cross The T's... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lipocine Inc

Aktien Top/Flop

Meistgelesene Nachrichten